NYSE · Healthcare · Medical Distribution · USA
Cencora Inc is a large cap company (market value between $10 billion and $200 billion) in the Medical Distribution industry.
Cencora distributes pharmaceuticals, medical supplies, and healthcare products to hospitals, pharmacies, clinics, and veterinarians across the United States and international markets. The company provides complementary services such as consulting, analytics, automation, and logistics to healthcare providers and pharmaceutical manufacturers. Operations are organized into U.S. Healthcare Solutions and International Healthcare Solutions segments.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Cencora Inc stock.
Overvalued: intrinsic value $260.48 per share, market price $340.00, margin of safety -30.5% (as of 2026-10-19).
Discounting its cash flows at 8.1% (average of 3 methods) values the shares at $260.48; the price of $340.00 is 31% above that value, and 79% of that value comes from beyond year five.
Leak Score: 56/100 on 12 of 12 signals (Weak Signal).
17 more funds hold it; the full list is part of the paid plan.
All 11 Medical Distribution stocks
COR is overvalued (as of the 2026-10-19 close). Discounting its cash flows at 8.1% (average of 3 methods) values the shares at $260.48; the price of $340.00 is 31% above that value, and 79% of that value comes from beyond year five.
$260.48 per share (as of the 2026-10-19 close), against a market price of $340.00. That is a margin of safety of -30.5%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
The price asks for more growth than the company has delivered. It needs the future to beat the past. Yearly sales growth the price needs: 21.2%. Yearly sales growth it has sustained: 11.5%.
56 out of 100, which we rate "Weak Signal", on 12 of 12 value investing signals.